The blockage of CCL2 receptor, CCR2 has been shown to induce phenotypic changes of adipocytes leading to improved lipid metabolism in the kidney of mice with diabetic nephropathy; the high level of CCL2 observed in DENV infection might interfere lipid metabolism through activation of CCR and its downstream pathway [92]. This evidence concerns the gene CCR2 and diabetic kidney disease.